Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Short-term Investments: 2019-2024

Historic Short-term Investments for CureVac N.V (CVAC) over the last 6 years, with Dec 2024 value amounting to $3.9 million.

  • CureVac N.V's Short-term Investments fell 12.45% to $3.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.5 million, marking a year-over-year decrease of 12.45%. This contributed to the annual value of $3.9 million for FY2024, which is 35.19% up from last year.
  • Latest data reveals that CureVac N.V reported Short-term Investments of $3.9 million as of FY2024, which was up 35.19% from $2.9 million recorded in FY2023.
  • CureVac N.V's 5-year Short-term Investments high stood at $5.3 million for FY2021, and its period low was $2.9 million during FY2023.
  • Over the past 3 years, CureVac N.V's median Short-term Investments value was $3.9 million (recorded in 2024), while the average stood at $3.8 million.
  • Per our database at Business Quant, CureVac N.V's Short-term Investments spiked by 93.49% in 2020 and then crashed by 37.46% in 2023.
  • CureVac N.V's Short-term Investments (Yearly) stood at $3.1 million in 2020, then soared by 70.28% to $5.3 million in 2021, then dropped by 13.90% to $4.6 million in 2022, then tumbled by 37.46% to $2.9 million in 2023, then spiked by 35.19% to $3.9 million in 2024.